Author

Wolfgang Glaesner

Observed names: Glaesner W, W. Glaesner

Institution: Eli Lilly (United States)

Observed institution: Eli Lilly (United States)

OpenAlex ID: A5044906331

Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein

2010 · Wolfgang Glaesner, Andrew Mark Vick, et al. · Diabetes/Metabolism Research and Reviews · 305

Glycosylation of Erythropoietin Affects Receptor Binding Kinetics: Role of Electrostatic Interactions

2002 · Ryan J. Darling, Uma Kuchibhotla, et al. · Biochemistry · 120

An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif

2022 · Deepa Balasubramaniam, Oliver Schroeder, et al. · Journal of Lipid Research · 53

Low incidence of anti‐drug antibodies in patients with type 2 diabetes treated with once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide

2016 · Z. Milicevic, G. Anglin, et al. · Diabetes Obesity and Metabolism · 32

A New Approach to Drug Therapy: Fc-Fusion Technology

2017 · Pechtner V, Karanikas CA, et al. · Primary Health Care Open Access · 18

A Model of Controlled Acute Hyperglycemia in Rats: Effects of Insulin and Glucagon-Like Peptide-1 Analog

2006 · Joy K. Saha, Jinqi Xia, et al. · Journal of Pharmacology and Experimental Therapeutics · 17

Molecular Insights into Fully Human and Humanized Monoclonal Antibodies: What are the Differences and Should Dermatologists Care?

2016 · Lotus Mallbris, Julian Davies, et al. · PubMed · 14

Low Incidence of Anti-Drug Antibodies in Type 2 Diabetes Patients Treated with Once Weekly GLP-1 Receptor Agonist Dulaglutide: Incidence of anti-drug antibodies with dulaglutide

2016 · Zvonko Miličević, Greg Anglin, et al. · 2

Pharmacological profile and clinical trial results of a long-acting, once weekly human GLP-1 receptor agonist Dulaglutide (Genetical Recombination)

2015 · Chihiro Tamaki, Masakazu Takeuchi, et al. · Folia Pharmacologica Japonica · 1

DPP‐4 Resistant Glucagon‐Like Peptide‐1 Analog LY548806: A Novel Agent for Control of Acute Hyperglycemia

2007 · Joy K Saha, Jinqi Xia, et al. · The FASEB Journal

Works count: 10

Citation count: 562

H-index: 7

I10-index: 7